The P144 TGF‐β1 inhibitor is a functionally activated TGF‐β1 inhibitor, and in vivo experiments have shown that it effectively inhibits liver and myocardial fibrosis. The gene discussed is TGFB1; the disease is Myocardial fibrosis.